nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—ADRB1—dilated cardiomyopathy	0.374	0.543	CbGaD
Mirtazapine—ADRB2—dilated cardiomyopathy	0.314	0.457	CbGaD
Mirtazapine—HTR2B—cardial valve—dilated cardiomyopathy	0.0154	0.249	CbGeAlD
Mirtazapine—CYP2C9—cardial valve—dilated cardiomyopathy	0.00995	0.161	CbGeAlD
Mirtazapine—SLC6A2—sympathetic nervous system—dilated cardiomyopathy	0.00537	0.0869	CbGeAlD
Mirtazapine—HTR7—pulmonary artery—dilated cardiomyopathy	0.00532	0.0861	CbGeAlD
Mirtazapine—HTR7—sympathetic nervous system—dilated cardiomyopathy	0.00517	0.0838	CbGeAlD
Mirtazapine—HTR2A—pulmonary artery—dilated cardiomyopathy	0.00332	0.0537	CbGeAlD
Mirtazapine—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.00323	0.0522	CbGeAlD
Mirtazapine—DRD4—heart—dilated cardiomyopathy	0.00231	0.0374	CbGeAlD
Mirtazapine—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.00147	0.00964	CcSEcCtD
Mirtazapine—ADRB1—cardiac ventricle—dilated cardiomyopathy	0.00135	0.0219	CbGeAlD
Mirtazapine—Apathy—Furosemide—dilated cardiomyopathy	0.00135	0.00885	CcSEcCtD
Mirtazapine—Flat affect—Furosemide—dilated cardiomyopathy	0.00133	0.00877	CcSEcCtD
Mirtazapine—Blister—Furosemide—dilated cardiomyopathy	0.00133	0.00877	CcSEcCtD
Mirtazapine—Lethargy—Spironolactone—dilated cardiomyopathy	0.00131	0.0086	CcSEcCtD
Mirtazapine—ADRB1—myocardium—dilated cardiomyopathy	0.00127	0.0206	CbGeAlD
Mirtazapine—Generalised oedema—Lisinopril—dilated cardiomyopathy	0.00121	0.00797	CcSEcCtD
Mirtazapine—Ataxia—Spironolactone—dilated cardiomyopathy	0.00121	0.00793	CcSEcCtD
Mirtazapine—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.0012	0.00786	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00115	0.00759	CcSEcCtD
Mirtazapine—Gastritis—Spironolactone—dilated cardiomyopathy	0.00113	0.00746	CcSEcCtD
Mirtazapine—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00111	0.00729	CcSEcCtD
Mirtazapine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0011	0.00722	CcSEcCtD
Mirtazapine—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00107	0.00702	CcSEcCtD
Mirtazapine—Gout—Furosemide—dilated cardiomyopathy	0.00103	0.00677	CcSEcCtD
Mirtazapine—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00102	0.00671	CcSEcCtD
Mirtazapine—ADRA2C—cardiac ventricle—dilated cardiomyopathy	0.00102	0.0165	CbGeAlD
Mirtazapine—Throat sore—Lisinopril—dilated cardiomyopathy	0.001	0.00658	CcSEcCtD
Mirtazapine—Laryngitis—Lisinopril—dilated cardiomyopathy	0.001	0.00658	CcSEcCtD
Mirtazapine—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.001	0.00658	CcSEcCtD
Mirtazapine—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.000991	0.00652	CcSEcCtD
Mirtazapine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.000988	0.0065	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000979	0.00644	CcSEcCtD
Mirtazapine—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.000957	0.0063	CcSEcCtD
Mirtazapine—ADRA2C—myocardium—dilated cardiomyopathy	0.000956	0.0155	CbGeAlD
Mirtazapine—Otitis media—Lisinopril—dilated cardiomyopathy	0.000926	0.00609	CcSEcCtD
Mirtazapine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000922	0.00606	CcSEcCtD
Mirtazapine—Memory impairment—Lisinopril—dilated cardiomyopathy	0.000919	0.00604	CcSEcCtD
Mirtazapine—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.000902	0.00593	CcSEcCtD
Mirtazapine—ADRB1—heart—dilated cardiomyopathy	0.000886	0.0143	CbGeAlD
Mirtazapine—Bladder pain—Furosemide—dilated cardiomyopathy	0.000869	0.00571	CcSEcCtD
Mirtazapine—Urine output increased—Furosemide—dilated cardiomyopathy	0.000869	0.00571	CcSEcCtD
Mirtazapine—HTR2B—heart—dilated cardiomyopathy	0.000848	0.0137	CbGeAlD
Mirtazapine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000839	0.00551	CcSEcCtD
Mirtazapine—Mental disability—Furosemide—dilated cardiomyopathy	0.000834	0.00548	CcSEcCtD
Mirtazapine—Breast pain—Lisinopril—dilated cardiomyopathy	0.000826	0.00543	CcSEcCtD
Mirtazapine—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000802	0.00527	CcSEcCtD
Mirtazapine—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.000798	0.00525	CcSEcCtD
Mirtazapine—Polyuria—Furosemide—dilated cardiomyopathy	0.000794	0.00522	CcSEcCtD
Mirtazapine—Arthropathy—Lisinopril—dilated cardiomyopathy	0.000793	0.00521	CcSEcCtD
Mirtazapine—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.000793	0.00521	CcSEcCtD
Mirtazapine—Cough increased—Lisinopril—dilated cardiomyopathy	0.000787	0.00518	CcSEcCtD
Mirtazapine—Alopecia—Spironolactone—dilated cardiomyopathy	0.000784	0.00515	CcSEcCtD
Mirtazapine—Deafness—Furosemide—dilated cardiomyopathy	0.00078	0.00513	CcSEcCtD
Mirtazapine—Gout—Lisinopril—dilated cardiomyopathy	0.000772	0.00508	CcSEcCtD
Mirtazapine—ADRB1—cardiac atrium—dilated cardiomyopathy	0.000758	0.0123	CbGeAlD
Mirtazapine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000739	0.00486	CcSEcCtD
Mirtazapine—Thirst—Furosemide—dilated cardiomyopathy	0.000733	0.00482	CcSEcCtD
Mirtazapine—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00073	0.0048	CcSEcCtD
Mirtazapine—Neck pain—Lisinopril—dilated cardiomyopathy	0.00073	0.0048	CcSEcCtD
Mirtazapine—HTR7—heart—dilated cardiomyopathy	0.000726	0.0118	CbGeAlD
Mirtazapine—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.000721	0.00474	CcSEcCtD
Mirtazapine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000716	0.00471	CcSEcCtD
Mirtazapine—Lethargy—Furosemide—dilated cardiomyopathy	0.000712	0.00468	CcSEcCtD
Mirtazapine—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.000704	0.00463	CcSEcCtD
Mirtazapine—ADRA1A—heart—dilated cardiomyopathy	0.000701	0.0113	CbGeAlD
Mirtazapine—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.0007	0.00461	CcSEcCtD
Mirtazapine—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.0007	0.0046	CcSEcCtD
Mirtazapine—Malaise—Spironolactone—dilated cardiomyopathy	0.000696	0.00458	CcSEcCtD
Mirtazapine—Cystitis—Lisinopril—dilated cardiomyopathy	0.000696	0.00458	CcSEcCtD
Mirtazapine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000691	0.00455	CcSEcCtD
Mirtazapine—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000684	0.0045	CcSEcCtD
Mirtazapine—ADRA2C—heart—dilated cardiomyopathy	0.000668	0.0108	CbGeAlD
Mirtazapine—Urinary retention—Furosemide—dilated cardiomyopathy	0.000663	0.00436	CcSEcCtD
Mirtazapine—Bladder pain—Lisinopril—dilated cardiomyopathy	0.000652	0.00429	CcSEcCtD
Mirtazapine—Discomfort—Spironolactone—dilated cardiomyopathy	0.000649	0.00427	CcSEcCtD
Mirtazapine—Dehydration—Furosemide—dilated cardiomyopathy	0.000649	0.00427	CcSEcCtD
Mirtazapine—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000642	0.00422	CcSEcCtD
Mirtazapine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000637	0.00419	CcSEcCtD
Mirtazapine—Confusional state—Spironolactone—dilated cardiomyopathy	0.000635	0.00418	CcSEcCtD
Mirtazapine—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000632	0.00416	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000628	0.00413	CcSEcCtD
Mirtazapine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000617	0.00406	CcSEcCtD
Mirtazapine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000615	0.00405	CcSEcCtD
Mirtazapine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000607	0.00399	CcSEcCtD
Mirtazapine—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000602	0.00396	CcSEcCtD
Mirtazapine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000599	0.00394	CcSEcCtD
Mirtazapine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000597	0.00393	CcSEcCtD
Mirtazapine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000591	0.00389	CcSEcCtD
Mirtazapine—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00059	0.00388	CcSEcCtD
Mirtazapine—ADRA2C—cardiac atrium—dilated cardiomyopathy	0.000571	0.00925	CbGeAlD
Mirtazapine—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000564	0.00371	CcSEcCtD
Mirtazapine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00056	0.00368	CcSEcCtD
Mirtazapine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000557	0.00366	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00055	0.00362	CcSEcCtD
Mirtazapine—CYP2C9—heart—dilated cardiomyopathy	0.00055	0.0089	CbGeAlD
Mirtazapine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000544	0.00358	CcSEcCtD
Mirtazapine—Arthritis—Lisinopril—dilated cardiomyopathy	0.000538	0.00354	CcSEcCtD
Mirtazapine—Drowsiness—Furosemide—dilated cardiomyopathy	0.000537	0.00353	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000533	0.0035	CcSEcCtD
Mirtazapine—ADRA2A—heart—dilated cardiomyopathy	0.000533	0.00863	CbGeAlD
Mirtazapine—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000525	0.00346	CcSEcCtD
Mirtazapine—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000523	0.00344	CcSEcCtD
Mirtazapine—Diplopia—Lisinopril—dilated cardiomyopathy	0.000523	0.00344	CcSEcCtD
Mirtazapine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000519	0.00341	CcSEcCtD
Mirtazapine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000519	0.00341	CcSEcCtD
Mirtazapine—Sweating—Furosemide—dilated cardiomyopathy	0.000515	0.00339	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000508	0.00334	CcSEcCtD
Mirtazapine—Face oedema—Lisinopril—dilated cardiomyopathy	0.000505	0.00332	CcSEcCtD
Mirtazapine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000502	0.0033	CcSEcCtD
Mirtazapine—Urticaria—Spironolactone—dilated cardiomyopathy	0.000501	0.00329	CcSEcCtD
Mirtazapine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000498	0.00328	CcSEcCtD
Mirtazapine—Ataxia—Lisinopril—dilated cardiomyopathy	0.000492	0.00324	CcSEcCtD
Mirtazapine—Dehydration—Lisinopril—dilated cardiomyopathy	0.000487	0.0032	CcSEcCtD
Mirtazapine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000478	0.00314	CcSEcCtD
Mirtazapine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000477	0.00313	CcSEcCtD
Mirtazapine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000473	0.00311	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000471	0.0031	CcSEcCtD
Mirtazapine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000464	0.00305	CcSEcCtD
Mirtazapine—Gastritis—Lisinopril—dilated cardiomyopathy	0.000463	0.00305	CcSEcCtD
Mirtazapine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000456	0.003	CcSEcCtD
Mirtazapine—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.000456	0.00738	CbGeAlD
Mirtazapine—HTR2A—heart—dilated cardiomyopathy	0.000453	0.00733	CbGeAlD
Mirtazapine—Asthma—Lisinopril—dilated cardiomyopathy	0.000452	0.00297	CcSEcCtD
Mirtazapine—Influenza—Lisinopril—dilated cardiomyopathy	0.000452	0.00297	CcSEcCtD
Mirtazapine—Eye disorder—Furosemide—dilated cardiomyopathy	0.000451	0.00297	CcSEcCtD
Mirtazapine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00045	0.00296	CcSEcCtD
Mirtazapine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000448	0.00295	CcSEcCtD
Mirtazapine—Pruritus—Spironolactone—dilated cardiomyopathy	0.000446	0.00293	CcSEcCtD
Mirtazapine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000443	0.00292	CcSEcCtD
Mirtazapine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000441	0.0029	CcSEcCtD
Mirtazapine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000441	0.0029	CcSEcCtD
Mirtazapine—Angiopathy—Furosemide—dilated cardiomyopathy	0.000438	0.00288	CcSEcCtD
Mirtazapine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000435	0.00286	CcSEcCtD
Mirtazapine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000431	0.00284	CcSEcCtD
Mirtazapine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000431	0.00283	CcSEcCtD
Mirtazapine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00043	0.00282	CcSEcCtD
Mirtazapine—Dysuria—Lisinopril—dilated cardiomyopathy	0.000423	0.00278	CcSEcCtD
Mirtazapine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000423	0.00278	CcSEcCtD
Mirtazapine—Malnutrition—Furosemide—dilated cardiomyopathy	0.00042	0.00276	CcSEcCtD
Mirtazapine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000417	0.00274	CcSEcCtD
Mirtazapine—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000417	0.00274	CcSEcCtD
Mirtazapine—Flatulence—Furosemide—dilated cardiomyopathy	0.000414	0.00272	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000413	0.00272	CcSEcCtD
Mirtazapine—Weight increased—Lisinopril—dilated cardiomyopathy	0.000412	0.00271	CcSEcCtD
Mirtazapine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000411	0.00271	CcSEcCtD
Mirtazapine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000409	0.00269	CcSEcCtD
Mirtazapine—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000406	0.00267	CcSEcCtD
Mirtazapine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000401	0.00263	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.0004	0.00263	CcSEcCtD
Mirtazapine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000398	0.00261	CcSEcCtD
Mirtazapine—Rash—Spironolactone—dilated cardiomyopathy	0.000397	0.00261	CcSEcCtD
Mirtazapine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000397	0.00261	CcSEcCtD
Mirtazapine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000395	0.0026	CcSEcCtD
Mirtazapine—Headache—Spironolactone—dilated cardiomyopathy	0.000395	0.0026	CcSEcCtD
Mirtazapine—Jaundice—Lisinopril—dilated cardiomyopathy	0.000393	0.00259	CcSEcCtD
Mirtazapine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000392	0.00258	CcSEcCtD
Mirtazapine—Anaemia—Furosemide—dilated cardiomyopathy	0.000388	0.00255	CcSEcCtD
Mirtazapine—Sweating—Lisinopril—dilated cardiomyopathy	0.000387	0.00254	CcSEcCtD
Mirtazapine—Agitation—Furosemide—dilated cardiomyopathy	0.000386	0.00254	CcSEcCtD
Mirtazapine—Haematuria—Lisinopril—dilated cardiomyopathy	0.000385	0.00253	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000381	0.00251	CcSEcCtD
Mirtazapine—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00038	0.0025	CcSEcCtD
Mirtazapine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000378	0.00249	CcSEcCtD
Mirtazapine—Vertigo—Furosemide—dilated cardiomyopathy	0.000377	0.00248	CcSEcCtD
Mirtazapine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000376	0.00248	CcSEcCtD
Mirtazapine—Leukopenia—Furosemide—dilated cardiomyopathy	0.000376	0.00247	CcSEcCtD
Mirtazapine—Nausea—Spironolactone—dilated cardiomyopathy	0.000374	0.00246	CcSEcCtD
Mirtazapine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000369	0.00242	CcSEcCtD
Mirtazapine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000363	0.00239	CcSEcCtD
Mirtazapine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000362	0.00238	CcSEcCtD
Mirtazapine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00036	0.00237	CcSEcCtD
Mirtazapine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000359	0.00236	CcSEcCtD
Mirtazapine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000358	0.00235	CcSEcCtD
Mirtazapine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000357	0.00235	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000355	0.00234	CcSEcCtD
Mirtazapine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000355	0.00233	CcSEcCtD
Mirtazapine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00035	0.0023	CcSEcCtD
Mirtazapine—Confusional state—Furosemide—dilated cardiomyopathy	0.000346	0.00227	CcSEcCtD
Mirtazapine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000342	0.00225	CcSEcCtD
Mirtazapine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000338	0.00222	CcSEcCtD
Mirtazapine—Shock—Furosemide—dilated cardiomyopathy	0.000337	0.00222	CcSEcCtD
Mirtazapine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000336	0.00221	CcSEcCtD
Mirtazapine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000336	0.00221	CcSEcCtD
Mirtazapine—Skin disorder—Furosemide—dilated cardiomyopathy	0.000333	0.00219	CcSEcCtD
Mirtazapine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000331	0.00218	CcSEcCtD
Mirtazapine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000328	0.00216	CcSEcCtD
Mirtazapine—Anorexia—Furosemide—dilated cardiomyopathy	0.000327	0.00215	CcSEcCtD
Mirtazapine—Chills—Lisinopril—dilated cardiomyopathy	0.000325	0.00214	CcSEcCtD
Mirtazapine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000323	0.00213	CcSEcCtD
Mirtazapine—Hypotension—Furosemide—dilated cardiomyopathy	0.00032	0.00211	CcSEcCtD
Mirtazapine—Alopecia—Lisinopril—dilated cardiomyopathy	0.00032	0.0021	CcSEcCtD
Mirtazapine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000317	0.00209	CcSEcCtD
Mirtazapine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000315	0.00207	CcSEcCtD
Mirtazapine—Flatulence—Lisinopril—dilated cardiomyopathy	0.000311	0.00204	CcSEcCtD
Mirtazapine—Tension—Lisinopril—dilated cardiomyopathy	0.000309	0.00203	CcSEcCtD
Mirtazapine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000309	0.00203	CcSEcCtD
Mirtazapine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000308	0.00202	CcSEcCtD
Mirtazapine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000306	0.00201	CcSEcCtD
Mirtazapine—Back pain—Lisinopril—dilated cardiomyopathy	0.000305	0.002	CcSEcCtD
Mirtazapine—Somnolence—Furosemide—dilated cardiomyopathy	0.000305	0.002	CcSEcCtD
Mirtazapine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000298	0.00196	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000296	0.00195	CcSEcCtD
Mirtazapine—Fatigue—Furosemide—dilated cardiomyopathy	0.000296	0.00194	CcSEcCtD
Mirtazapine—Tremor—Lisinopril—dilated cardiomyopathy	0.000295	0.00194	CcSEcCtD
Mirtazapine—Pain—Furosemide—dilated cardiomyopathy	0.000293	0.00193	CcSEcCtD
Mirtazapine—Constipation—Furosemide—dilated cardiomyopathy	0.000293	0.00193	CcSEcCtD
Mirtazapine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000292	0.00192	CcSEcCtD
Mirtazapine—Anaemia—Lisinopril—dilated cardiomyopathy	0.000291	0.00192	CcSEcCtD
Mirtazapine—Malaise—Lisinopril—dilated cardiomyopathy	0.000284	0.00187	CcSEcCtD
Mirtazapine—Vertigo—Lisinopril—dilated cardiomyopathy	0.000283	0.00186	CcSEcCtD
Mirtazapine—Syncope—Lisinopril—dilated cardiomyopathy	0.000283	0.00186	CcSEcCtD
Mirtazapine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000282	0.00186	CcSEcCtD
Mirtazapine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000282	0.00186	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00028	0.00184	CcSEcCtD
Mirtazapine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000279	0.00183	CcSEcCtD
Mirtazapine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000277	0.00182	CcSEcCtD
Mirtazapine—Cough—Lisinopril—dilated cardiomyopathy	0.000275	0.00181	CcSEcCtD
Mirtazapine—Urticaria—Furosemide—dilated cardiomyopathy	0.000272	0.00179	CcSEcCtD
Mirtazapine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000271	0.00178	CcSEcCtD
Mirtazapine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000271	0.00178	CcSEcCtD
Mirtazapine—Myalgia—Lisinopril—dilated cardiomyopathy	0.000268	0.00176	CcSEcCtD
Mirtazapine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000268	0.00176	CcSEcCtD
Mirtazapine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000268	0.00176	CcSEcCtD
Mirtazapine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000267	0.00176	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000266	0.00175	CcSEcCtD
Mirtazapine—Discomfort—Lisinopril—dilated cardiomyopathy	0.000265	0.00174	CcSEcCtD
Mirtazapine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000262	0.00173	CcSEcCtD
Mirtazapine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000259	0.00171	CcSEcCtD
Mirtazapine—Oedema—Lisinopril—dilated cardiomyopathy	0.000257	0.00169	CcSEcCtD
Mirtazapine—Infection—Lisinopril—dilated cardiomyopathy	0.000256	0.00168	CcSEcCtD
Mirtazapine—Shock—Lisinopril—dilated cardiomyopathy	0.000253	0.00166	CcSEcCtD
Mirtazapine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000253	0.00166	CcSEcCtD
Mirtazapine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000252	0.00166	CcSEcCtD
Mirtazapine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000251	0.00165	CcSEcCtD
Mirtazapine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00025	0.00164	CcSEcCtD
Mirtazapine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000249	0.00164	CcSEcCtD
Mirtazapine—Asthenia—Furosemide—dilated cardiomyopathy	0.000246	0.00162	CcSEcCtD
Mirtazapine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000245	0.00161	CcSEcCtD
Mirtazapine—Pruritus—Furosemide—dilated cardiomyopathy	0.000243	0.0016	CcSEcCtD
Mirtazapine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00024	0.00158	CcSEcCtD
Mirtazapine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000235	0.00154	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000234	0.00154	CcSEcCtD
Mirtazapine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000233	0.00153	CcSEcCtD
Mirtazapine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000231	0.00152	CcSEcCtD
Mirtazapine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000229	0.00151	CcSEcCtD
Mirtazapine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000229	0.0015	CcSEcCtD
Mirtazapine—Dizziness—Furosemide—dilated cardiomyopathy	0.000227	0.00149	CcSEcCtD
Mirtazapine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000226	0.00149	CcSEcCtD
Mirtazapine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000224	0.00147	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000222	0.00146	CcSEcCtD
Mirtazapine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000222	0.00146	CcSEcCtD
Mirtazapine—Pain—Lisinopril—dilated cardiomyopathy	0.00022	0.00145	CcSEcCtD
Mirtazapine—Constipation—Lisinopril—dilated cardiomyopathy	0.00022	0.00145	CcSEcCtD
Mirtazapine—Vomiting—Furosemide—dilated cardiomyopathy	0.000218	0.00143	CcSEcCtD
Mirtazapine—Rash—Furosemide—dilated cardiomyopathy	0.000216	0.00142	CcSEcCtD
Mirtazapine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000216	0.00142	CcSEcCtD
Mirtazapine—Headache—Furosemide—dilated cardiomyopathy	0.000215	0.00141	CcSEcCtD
Mirtazapine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000212	0.00139	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00021	0.00138	CcSEcCtD
Mirtazapine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000204	0.00134	CcSEcCtD
Mirtazapine—Nausea—Furosemide—dilated cardiomyopathy	0.000204	0.00134	CcSEcCtD
Mirtazapine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000203	0.00134	CcSEcCtD
Mirtazapine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000203	0.00134	CcSEcCtD
Mirtazapine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000189	0.00125	CcSEcCtD
Mirtazapine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000185	0.00121	CcSEcCtD
Mirtazapine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000182	0.0012	CcSEcCtD
Mirtazapine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000176	0.00116	CcSEcCtD
Mirtazapine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00017	0.00112	CcSEcCtD
Mirtazapine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000164	0.00108	CcSEcCtD
Mirtazapine—Rash—Lisinopril—dilated cardiomyopathy	0.000162	0.00107	CcSEcCtD
Mirtazapine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000162	0.00107	CcSEcCtD
Mirtazapine—Headache—Lisinopril—dilated cardiomyopathy	0.000161	0.00106	CcSEcCtD
Mirtazapine—Nausea—Lisinopril—dilated cardiomyopathy	0.000153	0.001	CcSEcCtD
Mirtazapine—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.89e-05	0.000192	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.89e-05	0.000192	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.88e-05	0.000191	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.87e-05	0.00019	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.87e-05	0.00019	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.86e-05	0.00019	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.85e-05	0.000188	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.85e-05	0.000188	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.85e-05	0.000188	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.85e-05	0.000188	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.82e-05	0.000186	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.82e-05	0.000185	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.82e-05	0.000185	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.81e-05	0.000185	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.81e-05	0.000184	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.81e-05	0.000184	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.81e-05	0.000184	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.81e-05	0.000184	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.8e-05	0.000183	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.8e-05	0.000183	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.8e-05	0.000183	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.79e-05	0.000182	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.78e-05	0.000181	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.77e-05	0.00018	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—RAF1—dilated cardiomyopathy	1.77e-05	0.00018	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.76e-05	0.00018	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.76e-05	0.000179	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.76e-05	0.000179	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.76e-05	0.000179	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.75e-05	0.000179	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.75e-05	0.000178	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.75e-05	0.000178	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.73e-05	0.000176	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.73e-05	0.000176	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.72e-05	0.000175	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.72e-05	0.000175	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.72e-05	0.000175	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.71e-05	0.000174	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.7e-05	0.000173	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.69e-05	0.000172	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.68e-05	0.000171	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.68e-05	0.000171	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.68e-05	0.000171	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.67e-05	0.00017	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.66e-05	0.000169	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.66e-05	0.000169	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.65e-05	0.000168	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	1.65e-05	0.000168	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.65e-05	0.000167	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.64e-05	0.000167	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.64e-05	0.000167	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.63e-05	0.000166	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.63e-05	0.000165	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.63e-05	0.000165	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.62e-05	0.000165	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.61e-05	0.000164	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	1.6e-05	0.000163	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.6e-05	0.000163	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.6e-05	0.000163	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.6e-05	0.000162	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.59e-05	0.000162	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.59e-05	0.000162	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.58e-05	0.00016	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.58e-05	0.00016	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.57e-05	0.00016	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	1.57e-05	0.00016	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.57e-05	0.00016	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.56e-05	0.000159	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.56e-05	0.000159	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.56e-05	0.000159	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.56e-05	0.000159	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.55e-05	0.000158	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.55e-05	0.000158	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.54e-05	0.000157	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.53e-05	0.000156	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.53e-05	0.000156	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.53e-05	0.000156	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.52e-05	0.000155	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.52e-05	0.000155	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.51e-05	0.000154	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.5e-05	0.000153	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.5e-05	0.000152	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.49e-05	0.000152	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.48e-05	0.000151	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.48e-05	0.000151	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.48e-05	0.00015	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.47e-05	0.000149	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.46e-05	0.000149	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.45e-05	0.000148	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.45e-05	0.000148	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.45e-05	0.000148	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.45e-05	0.000147	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.43e-05	0.000146	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.43e-05	0.000146	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.43e-05	0.000145	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.43e-05	0.000145	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.42e-05	0.000145	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.42e-05	0.000145	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.42e-05	0.000145	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.42e-05	0.000145	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.42e-05	0.000144	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.41e-05	0.000143	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.4e-05	0.000143	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.4e-05	0.000143	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.4e-05	0.000143	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.4e-05	0.000142	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.39e-05	0.000141	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.38e-05	0.000141	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—RAC1—dilated cardiomyopathy	1.38e-05	0.000141	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.38e-05	0.00014	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.38e-05	0.00014	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.36e-05	0.000139	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.35e-05	0.000137	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AGT—dilated cardiomyopathy	1.34e-05	0.000136	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.33e-05	0.000136	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—RAC1—dilated cardiomyopathy	1.32e-05	0.000135	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.32e-05	0.000134	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AGT—dilated cardiomyopathy	1.32e-05	0.000134	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.32e-05	0.000134	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.32e-05	0.000134	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.31e-05	0.000134	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.3e-05	0.000132	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.3e-05	0.000132	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.3e-05	0.000132	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	1.29e-05	0.000131	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.28e-05	0.00013	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.28e-05	0.00013	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.27e-05	0.000129	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AGT—dilated cardiomyopathy	1.26e-05	0.000129	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.26e-05	0.000128	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	1.26e-05	0.000128	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.22e-05	0.000124	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.21e-05	0.000124	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	1.21e-05	0.000123	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.2e-05	0.000122	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.2e-05	0.000122	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.2e-05	0.000122	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.18e-05	0.000121	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.18e-05	0.00012	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.18e-05	0.00012	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.17e-05	0.00012	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.16e-05	0.000118	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.16e-05	0.000118	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.15e-05	0.000117	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.14e-05	0.000116	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.14e-05	0.000116	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.14e-05	0.000116	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.14e-05	0.000116	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.13e-05	0.000115	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	1.13e-05	0.000115	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.13e-05	0.000115	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	1.12e-05	0.000114	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.12e-05	0.000114	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.11e-05	0.000113	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.1e-05	0.000112	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.09e-05	0.000111	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.08e-05	0.00011	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.07e-05	0.000109	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.06e-05	0.000108	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	1.05e-05	0.000107	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.05e-05	0.000107	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.04e-05	0.000105	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.02e-05	0.000104	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	1.02e-05	0.000104	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	1.02e-05	0.000104	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	1.02e-05	0.000104	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.02e-05	0.000104	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.01e-05	0.000103	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	1e-05	0.000102	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.95e-06	0.000101	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.93e-06	0.000101	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	9.91e-06	0.000101	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.91e-06	0.000101	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.79e-06	9.96e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	9.78e-06	9.95e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.77e-06	9.94e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	9.73e-06	9.9e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.72e-06	9.89e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.72e-06	9.89e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.59e-06	9.76e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	9.47e-06	9.63e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	9.31e-06	9.47e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	9.19e-06	9.36e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—RAF1—dilated cardiomyopathy	9.16e-06	9.32e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.04e-06	9.2e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.03e-06	9.19e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	8.99e-06	9.15e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.91e-06	9.06e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	8.84e-06	9e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—RAC1—dilated cardiomyopathy	8.83e-06	8.98e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—RAF1—dilated cardiomyopathy	8.77e-06	8.92e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	8.66e-06	8.81e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	8.59e-06	8.74e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	8.45e-06	8.6e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AGT—dilated cardiomyopathy	8.43e-06	8.58e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	8.37e-06	8.52e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	8.32e-06	8.47e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	8.27e-06	8.42e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.24e-06	8.38e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	8.11e-06	8.25e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.06e-06	8.2e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	8.05e-06	8.19e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.88e-06	8.02e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.84e-06	7.98e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	7.79e-06	7.93e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	7.69e-06	7.82e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.63e-06	7.76e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	7.3e-06	7.43e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.1e-06	7.22e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	6.94e-06	7.07e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.92e-06	7.04e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	6.83e-06	6.95e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.81e-06	6.93e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.79e-06	6.91e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	6.79e-06	6.91e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	6.77e-06	6.89e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	6.75e-06	6.87e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.67e-06	6.78e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	6.65e-06	6.77e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	6.6e-06	6.71e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	6.57e-06	6.69e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	6.38e-06	6.49e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—EGFR—dilated cardiomyopathy	6.28e-06	6.39e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.19e-06	6.3e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—EGFR—dilated cardiomyopathy	6.01e-06	6.12e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	5.99e-06	6.1e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	5.96e-06	6.07e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	5.94e-06	6.04e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	5.86e-06	5.97e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—RAF1—dilated cardiomyopathy	5.85e-06	5.96e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	5.79e-06	5.89e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	5.74e-06	5.84e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	5.74e-06	5.84e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	5.64e-06	5.74e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	5.34e-06	5.44e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	5.34e-06	5.43e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	5.08e-06	5.17e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.87e-06	4.95e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	4.76e-06	4.85e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.66e-06	4.74e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	4.63e-06	4.71e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	4.5e-06	4.58e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	4.47e-06	4.55e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	4.35e-06	4.43e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	4.09e-06	4.16e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.02e-06	4.09e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.01e-06	4.08e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.94e-06	4.01e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	3.92e-06	3.99e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.66e-06	3.72e-05	CbGpPWpGaD
